![]() The VITTAL trial assessed “transplantability” of discarded livers with NMP and evaluated 90-day outcomes in these grafts. ![]() Friend 7, Christina Yap 8, Simon Charles Afford 2 and Darius F Mirza 1, (1)Liver Surgery, University Hospitals Birmingham NHS Foundation Trust, (2)Centre for Liver Research, University of Birmingham, (3)Institute of Cancer and Genomics Sciences, University of Birmingham, (4)Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham, (5)Department of Cancer Research UK Clinical Trials Unit, University of Birmingham, (6)Department of Cellular Pathology, University of Birmingham, (7)Nuffield Department of Surgical Sciences, University of Oxford, (8)Cancer Research UK Clinical Trials Unit, University of Birminghamīackground: Surgeons frequently reject high-risk donor livers, which currently comprise the only increasing and underutilised donor resource. Hubscher 6, Lorraine Wallace 2, Paolo Muiesan 1, John Isaac 1, Keith Roberts 1, Manuel Abradelo 1, Hentie Cilliers 1, John Isaac 1, Julian Bion 1, Peter J. Perera 4, Yuri Boteon 2, Joseph Attard 2, Darren Barton 5, Manpreet Wilkhu 5, Stuart Curbishley 2, Desley A Neil 1, Stefan G. ![]() Hynek Mergental 1, Richard W Laing 1,2, Amanda J Kirkham 3, Thamara P.R. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |